Novel Approach to Specific Growth Factor Inhibition in Vivo
- 1 January 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (1) , 169-179
- https://doi.org/10.1016/s0002-9440(10)65263-7
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 39 references indexed in Scilit:
- Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivoKidney International, 1997
- DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice.Journal of Clinical Investigation, 1996
- The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis.Journal of Clinical Investigation, 1996
- Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized ratsKidney International, 1996
- Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblastsKidney International, 1995
- Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokinesClinical and Experimental Immunology, 1991
- Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.Journal of Clinical Investigation, 1991
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- Progression of Renal DiseaseNew England Journal of Medicine, 1988